Comparison

Tedalinab European Partner

Item no. HY-14900-100mg
Manufacturer MedChem Express
CASRN 916591-01-0
Amount 100 mg
Category
Type Chemicals
Specific against other
Purity 99.94
Formula C19H21F2N3O
Citations [1]Glenmark’s molecule for neuropathic pain, osteoarthritis - GRC 10693, successfully completes Phase I trials.
Smiles O=C(C1=NN(C2=CC=C(F)C=C2F)C3=C1[C@@]4([H])CC[C@]3([H])C4)NC(C)(C)C
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias GRC-10693
Available
Product Description
Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment[1].
StorageTemperature
-20°C, 3 years (Powder)
Shipping
Blue Ice
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
345.39
Clinical_Information
No Development Reported
Manufacturers Research_Area
Inflammation/Immunology
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
Cannabinoid Receptor
Isoform
CB2
Pathway
GPCR/G Protein; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close